首页> 外文OA文献 >Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffolds
【2h】

Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffolds

机译:基于4-氨基苯并ze庚酮(Aba),氮杂吲哚(Aia)和四氢异喹啉(Tic)支架的新型多种阿片样物质配体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The dimerization and trimerization of the Dmt-Tic, Dmt-Aia and Dmt-Aba pharmacophores provided multiple ligands which were evaluated in vitro for opioid receptor binding and functional activity. Whereas the Tic- and Aba multimers proved to be dual and balanced delta/mu antagonists, as determined by the functional [S(35)]GTPgammaS binding assay, the dimerization of potent Aia-based 'parent' ligands unexpectedly resulted in substantial less efficient receptor binding and non-active dimeric compounds.
机译:Dmt-Tic,Dmt-Aia和Dmt-Aba药效团的二聚和三聚提供了多种配体,这些配体在体外评估了阿片样物质受体的结合和功能活性。正如功能性[S(35)] GTPgammaS结合试验所确定的那样,Tic-和Aba多聚体被证明是双重且平衡的delta / mu拮抗剂,有效的基于Aia的“父母”配体的二聚作用出乎意料地导致效率大大降低受体结合和非活性二聚化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号